Market Research Logo

La Jolla Pharmaceutical Company - Product Pipeline Review - 2016

La Jolla Pharmaceutical Company - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘La Jolla Pharmaceutical Company - Product Pipeline Review - 2016’, provides an overview of the La Jolla Pharmaceutical Company’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by La Jolla Pharmaceutical Company, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of La Jolla Pharmaceutical Company
  • The report provides overview of La Jolla Pharmaceutical Company including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses La Jolla Pharmaceutical Company’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features La Jolla Pharmaceutical Company’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate La Jolla Pharmaceutical Company’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for La Jolla Pharmaceutical Company
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding La Jolla Pharmaceutical Company’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


La Jolla Pharmaceutical Company Snapshot
La Jolla Pharmaceutical Company Overview
Key Information
Key Facts
La Jolla Pharmaceutical Company - Research and Development Overview
Key Therapeutic Areas
La Jolla Pharmaceutical Company - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
La Jolla Pharmaceutical Company - Pipeline Products Glance
La Jolla Pharmaceutical Company - Late Stage Pipeline Products
Phase III Products/Combination Treatment Modalities
La Jolla Pharmaceutical Company - Clinical Stage Pipeline Products
Phase I Products/Combination Treatment Modalities
La Jolla Pharmaceutical Company - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
La Jolla Pharmaceutical Company - Unknown Stage Pipeline Products
Unknown Products/Combination Treatment Modalities
La Jolla Pharmaceutical Company - Drug Profiles
LJPC-501
Product Description
Mechanism of Action
R&D Progress
LJPC-401
Product Description
Mechanism of Action
R&D Progress
LJPC-0712
Product Description
Mechanism of Action
R&D Progress
LJPC-30Sa
Product Description
Mechanism of Action
R&D Progress
LJPC-30Sb
Product Description
Mechanism of Action
R&D Progress
LJPC-6417
Product Description
Mechanism of Action
R&D Progress
Small Molecule 1 To Inhibit ALK2 for Fibrodysplasia Ossificans Progressiva
Product Description
Mechanism of Action
R&D Progress
Small Molecule 2 To Inhibit ALK2 for Fibrodysplasia Ossificans Progressiva
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit BMP for Cardiovascular, CNS, Oncology and Musculoskeletal Disorders
Product Description
Mechanism of Action
R&D Progress
Drugs for Undisclosed Indications
Product Description
Mechanism of Action
R&D Progress
La Jolla Pharmaceutical Company - Pipeline Analysis
La Jolla Pharmaceutical Company - Pipeline Products by Target
La Jolla Pharmaceutical Company - Pipeline Products by Route of Administration
La Jolla Pharmaceutical Company - Pipeline Products by Molecule Type
La Jolla Pharmaceutical Company - Pipeline Products by Mechanism of Action
La Jolla Pharmaceutical Company - Recent Pipeline Updates
La Jolla Pharmaceutical Company - Dormant Projects
La Jolla Pharmaceutical Company - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
GCS-100
LJPC-1010
La Jolla Pharmaceutical Company - Company Statement
La Jolla Pharmaceutical Company - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
La Jolla Pharmaceutical Company, Key Information
La Jolla Pharmaceutical Company, Key Facts
La Jolla Pharmaceutical Company - Pipeline by Indication, 2016
La Jolla Pharmaceutical Company - Pipeline by Stage of Development, 2016
La Jolla Pharmaceutical Company - Monotherapy Products in Pipeline, 2016
La Jolla Pharmaceutical Company - Phase III, 2016
La Jolla Pharmaceutical Company - Phase I, 2016
La Jolla Pharmaceutical Company - Preclinical, 2016
La Jolla Pharmaceutical Company - Discovery, 2016
La Jolla Pharmaceutical Company - Unknown, 2016
La Jolla Pharmaceutical Company - Pipeline by Target, 2016
La Jolla Pharmaceutical Company - Pipeline by Route of Administration, 2016
La Jolla Pharmaceutical Company - Pipeline by Molecule Type, 2016
La Jolla Pharmaceutical Company - Pipeline Products by Mechanism of Action, 2016
La Jolla Pharmaceutical Company - Recent Pipeline Updates, 2016
La Jolla Pharmaceutical Company - Dormant Developmental Projects,2016
La Jolla Pharmaceutical Company - Discontinued Pipeline Products, 2016
La Jolla Pharmaceutical Company, Subsidiaries
List of Figures
La Jolla Pharmaceutical Company - Pipeline by Top 10 Indication, 2016
La Jolla Pharmaceutical Company - Pipeline by Stage of Development, 2016
La Jolla Pharmaceutical Company - Monotherapy Products in Pipeline, 2016
La Jolla Pharmaceutical Company - Pipeline by Target, 2016
La Jolla Pharmaceutical Company - Pipeline by Route of Administration, 2016
La Jolla Pharmaceutical Company - Pipeline by Molecule Type, 2016
La Jolla Pharmaceutical Company - Pipeline Products by Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report